Global Neurodegenerative Diseases Drugs Market Size, Share & Forecast 2025–2034

The global neurodegenerative diseases drugs market was valued at USD 44.69 Billion in 2024 and is expected to reach USD 88.74 Billion by 2034, growing at a CAGR of 7.10%. The market is driven by the increasing prevalence of neurodegenerative conditions such as Alzheimer’s and Parkinson’s across the 8 major markets, along with rising demand for advanced therapeutics.